Rinaldi Fontani Institute, Florence, Italy.
Indian J Med Res. 2010 Aug;132:189-94.
BACKGROUND & OBJECTIVES: Chronic social stress is an important factor responsible for the worsening of depressive disorders in humans. In this study we present the relational Neuro-Psycho-Physical Optimization (NPPO) with Radio Electric Asymmetric Conveyer (REAC-CRM) as the treatment to tackle the unconscious dysfunction adjustments carried out by the central nervous system as a response to environmental stresses.
Psychological stress was measured in a group of 888 patients using the Psychological Stress Measure (PSM) test, a self-administered questionnaire. Data were collected immediately before and after the 4-wk therapy cycle. The detection of anxiety and depression clusters by PSM test has been based on the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR, APA, 2000) criteria. Six hundred and eighty eight patients (212 males, 476 females, average PSM test total scores 107.9 +/- 23.13) were treated with REAC-CRM therapy; 200 (64 males, 136 females, average PSM test total scores 107.86 +/- 25.80) were treated with "placebo REAC-CRM therapy"and used as control.
This study showed a significant reduction in scores measuring subjective perceptions of stress in the patients treated with a cycle of REAC-CRM therapy. At the end-point the number of patients reporting symptoms of stress-related anxiety and depression on the PSM test was significantly reduced (P<0.001); in the placebo group no significant difference was highlighted.
INTERPRETATION & CONCLUSIONS: NPPO therapy with a cycle of REAC-CRM was shown to reduce subjective perceptions of stress measured by the PSM test and in particular, symptoms of stress-related anxiety and depression.
慢性社会压力是导致人类抑郁障碍恶化的一个重要因素。本研究提出了神经心理物理优化(NPPO)与无线电不对称传输(REAC-CRM)的关系,作为一种治疗方法,以解决中枢神经系统对环境压力作出的无意识功能失调调整。
使用心理应激量表(PSM)测试对 888 例患者进行心理应激测量,PSM 测试是一种自我管理问卷。数据在 4 周治疗周期前后采集。通过 PSM 测试对焦虑和抑郁簇的检测是基于《精神障碍诊断与统计手册》(DSM-IV-TR,APA,2000)标准。688 例患者(212 例男性,476 例女性,PSM 测试总分平均 107.9 +/- 23.13)接受 REAC-CRM 治疗;200 例患者(64 例男性,136 例女性,PSM 测试总分平均 107.86 +/- 25.80)接受“安慰剂 REAC-CRM 治疗”,作为对照组。
本研究显示,接受 REAC-CRM 治疗周期的患者的应激主观感知评分显著降低。在终点时,报告 PSM 测试应激相关焦虑和抑郁症状的患者数量显著减少(P<0.001);安慰剂组则没有明显差异。
REAC-CRM 循环的 NPPO 治疗被证明可以减轻 PSM 测试测量的应激主观感知,特别是应激相关焦虑和抑郁症状。